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Abstract
The positioning and the elongation of the mitotic spindle must be
carefully regulated. In human cells, the evolutionary conserved
proteins LGN/Gai1-3 anchor the coiled-coil protein NuMA and
dynein to the cell cortex during metaphase, thus ensuring proper
spindle positioning. The mechanisms governing cortical localiza-
tion of NuMA and dynein during anaphase remain more elusive.
Here, we report that LGN/Gai1-3 are dispensable for NuMA-
dependent cortical dynein enrichment during anaphase. We further
establish that NuMA is excluded from the equatorial region of the
cell cortex in a manner that depends on the centralspindlin
components CYK4 and MKLP1. Importantly, we reveal that NuMA
can directly associate with PtdInsP (PIP) and PtdInsP2 (PIP2)
phosphoinositides in vitro. Furthermore, chemical or enzymatic
depletion of PIP/PIP2 prevents NuMA cortical localization during
mitosis, and conversely, increasing PIP2 levels augments mitotic
cortical NuMA. Overall, our study uncovers a novel function for
plasma membrane phospholipids in governing cortical NuMA
distribution and thus the proper execution of mitosis.
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Introduction
Accurate positioning and elongation of the mitotic spindle are criti-
cal processes for error-free cell division. In animal cells, metaphase
spindle positioning is dependent on an evolutionary conserved
ternary complex consisting of a large coiled-coil protein, a GoLoCo
domain containing protein, and a heterotrimeric G protein alpha
subunit (reviewed in Kotak & Go¨nczy, 2013; Siller & Doe, 2009). In
human cells, the members of this ternary complex are NuMA/LGN/
Gai1–3, and they serve to anchor the minus-end-directed motor
protein complex dynein (hereafter referred to as dynein for simplic-
ity) at the cell cortex during metaphase (Woodard et al, 2010;
Kiyomitsu & Cheeseman, 2012; Kotak et al, 2012). Such cortically
anchored dynein is thought to regulate spindle positioning by exert-
ing a pull on the plus-end of astral microtubules and/or by its capa-
bility to remain associated with force-generating depolymerizing
microtubules (reviewed in Kotak & Go¨nczy, 2013).
In addition to its role in spindle positioning, NuMA is also
required for proper assembly and maintenance of the mitotic spindle
(Yang & Snyder, 1992; Merdes et al, 1996). NuMA is a 2115 amino
acid-long protein that comprises globular head and tail domains
separated by a large coiled-coil moiety (Yang et al, 1992). An
N-terminal fragment of NuMA can interact with dynein (Kotak et al,
2012), whereas the tail domain contains microtubule and LGN bind-
ing sites, as well as a nuclear localization signal (NLS) (Du &
Macara, 2004). During metaphase, NuMA becomes weakly localized
in the cortical regions situated above the two spindle poles as a
result of its interaction with LGN/Gai1-3 (Du & Macara, 2004;
Woodard et al, 2010; Kiyomitsu & Cheeseman, 2012). Cortical levels
of NuMA/dynein increase as cells progress from metaphase to
anaphase, and such enrichment is crucial for robust spindle elonga-
tion (Collins et al, 2012; Kiyomitsu & Cheeseman, 2013; Kotak et al,
2013). NuMA can associate with several partners, including
ERM 4.1 proteins (reviewed in Radulescu & Cleveland, 2010;
Mattagajasingh et al, 1999), and it has been proposed that protein
4.1R and the related 4.1G together act as cortical anchors for NuMA
during anaphase (Kiyomitsu & Cheeseman, 2013). During meta-
phase, the presence of Ran-GTP in the vicinity of chromosomes
excludes NuMA from the equatorial cortical region and thus
confines it to the polar regions (Kiyomitsu & Cheeseman, 2012).
During anaphase, NuMA is also excluded from the equatorial
cortical region (Kiyomitsu & Cheeseman, 2013; Kotak et al, 2013),
but the mechanisms that operate at that stage to ensure continued
equatorial exclusion remain to be discovered.
Centralspindlin is an evolutionary conserved complex that
promotes cytokinesis in animal cells (reviewed in Glotzer, 2009). In
human cells, this complex comprises two molecules of the Rho-
family GTPase-activating protein CYK4 (also known as MgcRacGAP)
and two molecules of the kinesin MKLP1 (Mishima et al, 2002;
Pavicic-Kaltenbrunner et al, 2007; Loria et al, 2012). Centralspindlin
promotes the activity of the small GTPases RhoA and Rac during
furrow ingression, and is thus required for cytokinesis (Canman
et al, 2008; Bastos et al, 2012; Loria et al, 2012). The central-
spindlin component CYK4 directly associates with polyanionic
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phosphoinositides through a stretch of basic residues in its C1
domain, thus targeting CYK4 to the equatorial cortical region of the
plasma membrane (Lekomtsev et al, 2012). Intriguingly, this locali-
zation is reciprocal to that of cortical NuMA, but whether there
might be a relationship between these two components has not been
investigated to date.
Here, we report that the ternary complex components LGN/Gai1-3
are dispensable for NuMA/dynein localization to the cell cortex
during anaphase. Furthermore, we uncover that the centralspindlin
components CYK4 and MKLP1 are essential for excluding anaphase
NuMA from the equatorial cortical region. We identify a small
region within NuMA that targets the protein to the plasma
membrane through interaction with the polyanionic phosphoinosi-
tides PIP and PIP2. Importantly, through chemical and enzymatic
modulation, we demonstrate that the localization of NuMA is
governed by such phosphoinositides during anaphase in vivo.
Furthermore, we illustrate that premature increase in the levels of
such membrane lipids during metaphase causes NuMA-dependent
spindle positioning defects.
Results
LGN/Gai1-3 are dispensable for cortical dynein localization
during anaphase
In HeLa cells, cortical levels of dynein markedly increase in the
polar regions of the cell during progression from metaphase to
anaphase, and this in a NuMA-dependent manner (compare Fig 1D
with A; Kiyomitsu & Cheeseman, 2013; Kotak et al, 2013).
Anaphase cortical NuMA/dynein contributes to spindle elongation
during anaphase (Kotak et al, 2013) and is found in close proximity
of astral microtubules at that stage (Supplementary Fig S1A). We
discovered that cortical LGN, which is present in metaphase just like
NuMA/dynein (Woodard et al, 2010; Kiyomitsu & Cheeseman,
2012), is barely detected in anaphase cells (compare Supplementary
Fig S1D with B). This prompted us to investigate whether LGN and
Gai1-3 are required for anaphase NuMA/dynein cortical localization.
We found that depleting LGN does not alter the anaphase cortical
localization of NuMA, or of the dynein-associated dynactin compo-
nent p150Glued (Fig 1E, compare to 1B; see Supplementary Fig S1C
and E for depletion efficiency). These results are consistent with
recent findings by others (Kiyomitsu & Cheeseman, 2013; Zheng
et al, 2014). Furthermore, we found that a GFP-NuMA fusion
protein lacking a motif that is essential for interaction with LGN
during metaphase [GFP-NuMA(DLGN)] (Du et al, 2001; Du & Macara,
2004) does not localize to the cortex in metaphase (Fig 1G and I),
but is cortical in anaphase (Fig 1N).
Because another GoLoco domain protein can substitute for LGN
in regulating spindle positioning in a Gai-dependent manner in
some settings (Sanada & Tsai, 2005), we wondered whether an
analogous situation may be at play during anaphase in HeLa cells.
Therefore, we analysed the cortical distribution of NuMA/p150Glued
upon compromised Gai1-3 function. As shown in Fig 1C and F and
Supplementary Fig S1F–M, we found that the depletion of Gai1-3 by
siRNAs or their inactivation with Pertussis toxin does not affect
NuMA/p150Glued cortical localization in anaphase, in contrast to
their impact in metaphase.
NuMA is phosphorylated on T2055 by CDK1/cyclinB (hereafter
referred as CDK1), and such phosphorylation negatively regulates
cortical NuMA localization during metaphase (Kiyomitsu &
Cheeseman, 2013; Kotak et al, 2013; Seldin et al, 2013). Accord-
ingly, premature inhibition of CDK1 with RO-3306 or expression of a
T2055A non-phosphorylatable version of NuMA [GFP-NuMA(T>A)]
causes precocious strong enrichment of NuMA/dynein in meta-
phase, thus generating anaphase-like conditions (Kotak et al, 2013).
Here, we found that depletion of LGN by siRNAs or inactivation of
Gai function by Pertussis toxin does not impair anaphase-like
NuMA cortical enrichment in cells treated with RO-3306 (Supple-
mentary Fig S1N–Q). The same holds upon expression of
GFP-NuMA(DLGN, T>A), which in addition to bearing the T2055A
mutation also lacks the LGN binding domain (Fig 1G, J and O).
Overall, our results indicate that NuMA/dynein localization in
the polar regions of the cell cortex during anaphase is LGN- and
Gai1–3-independent and that premature inactivation of CDK1 mimics
anaphase-like cortical localization of NuMA/p150Glued.
Centralspindlin components negatively regulate cortical NuMA in
the equatorial region during anaphase
Why is anaphase cortical NuMA distribution restricted to the polar
regions? We set out to address this question by investigating how
Figure 1. Anaphase cortical NuMA/dynein localization is LGN/Gai(1-3) independent.
A–F HeLa cells in metaphase or anaphase, as indicated, transfected with control siRNAs (A, D), siRNAs against LGN (B, E) or Gai(1-3) (C, F), fixed 72 h thereafter and
stained for NuMA (red) as well as p150Glued (green). In this and other figures, DNA is visualized in blue and arrows point to cortical localization. In metaphase, 95%
of control cells exhibited weak cortical p150Glued staining, as shown, but this was the case for only 2% of LGN (RNAi) and 5% of Gai(1-3) (RNAi) cells, respectively. In
anaphase, 100% of control cells, 98% of LGN (RNAi) cells, and 96% of Gai(1-3) (RNAi) cells exhibited strong cortical NuMA/p150
Glued signal as shown (n > 100 cells
for all cases).
G Schematic representation of NuMA constructs used for the experiments shown on the right; the coiled-coil domain, the regions mediating interaction with LGN
and microtubules (MT), the nuclear localization signal (NLS) and T2055 are represented.
H–Q Images from time-lapse microscopy of HeLa cells stably expressing mCherry-H2B and transfected with GFP-NuMA (H, M), GFP-NuMADLGN (I, N),
GFP-NuMA(DLGN, T>A) (J, O), GFP-NuMAD4.1 (K, P) or GFP-NuMA(D4.1, T>A) (L, Q) in cells depleted of endogenous NuMA by RNAi for 72 h. The GFP signal is shown in
white, the mCherry signal in pink. 4% of cells transfected with GFP-NuMA(DLGN) exhibited cortical GFP localization in metaphase, whereas 100% of such cells
exhibited strong cortical GFP localization in anaphase. GFP-NuMA(DLGN, T>A) localizes to the cell cortex during metaphase in 100% of cells. Metaphase and
anaphase cells expressing GFP-NuMA(D4.1) harbor GFP signal at the cortex similar to wild-type NuMA in 98% of the cells; note also that GFP-NuMA(D4.1, T>A) is
strongly enriched at the plasma membrane already in metaphase. More than 50 cells were analysed by visual inspection in each case. Moreover, quantification of
cortical enrichment is shown on the right for metaphase (Met) and anaphase (Ana) for 10 cells in each condition; see Materials and Methods (P < 0.0005 between
metaphase and anaphase for GFP-NuMA, GFP-NuMADLGN, or GFP-NuMA(D4.1); P = 0.7 and P = 0.1 between metaphase and anaphase for GFP-NuMA(DLGN, T>A) and
GFP-NuMA(D4.1, T>A), respectively; error bars, s.d.).
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NuMA/p150Glued is prevented from occupying the equatorial cortical
region (Fig 1D; Collins et al, 2012; Kiyomitsu & Cheeseman, 2013;
Kotak et al, 2013). During metaphase, Ran-GTP emanating from the
centrally located chromatin negatively regulates NuMA distribution
in the equatorial cortical region (Kiyomitsu & Cheeseman, 2012;
Bird et al, 2013). We reasoned that this mechanism is unlikely to
operate during anaphase, because chromosomes occupy a more
polar position at that time (see Fig 1D). Nonetheless, we investi-
gated this possibility by analysing NuMA localization in anaphase
cells expressing a dominant-negative form of Ran (GFP-RanT24N)
or treated with Importazole, a small molecule inhibitor of Ran-GTP
(Soderholm et al, 2011). Whereas both conditions influence the
metaphase distribution of NuMA/dynein (Kiyomitsu & Cheeseman,
2012; Bird et al, 2013), we found by contrast that they do not alter
cortical NuMA distribution in anaphase cells (Supplementary Fig
S2A and B). We conclude that Ran-GTP does not modulate the
spatial distribution of cortical NuMA during anaphase.
Since components of the cytokinetic machinery, including the
centralspindlin components CYK4 and MKLP1, occupy the equato-
rial cortical region starting in anaphase (Fig 2A and Supplementary
Movie S1), we addressed whether centralspindlin is responsible for
excluding NuMA from this region. Importantly, we found that cells
depleted of CYK4 (Fig 2B–D) or of MKLP1 fail to exclude NuMA
from the equatorial cortical region during anaphase (Fig 2E–H,
Supplementary Fig S2C and D). To test whether this lack of exclu-
sion is specific to the depletion of centralspindlin components or
instead occurs irrespective of the cause of cytokinesis failure, we
treated mitotic cells with the Rock-kinase inhibitor Y27632. Such
treatment did not impair the exclusion of NuMA from the equatorial
cortical region (Supplementary Fig S2E and F), indicating that
impairing cleavage furrow contractility does not prevent NuMA
equatorial exclusion. Although the biological significance of the lack
of cortical NuMA/dynein in this area remains to be determined, we
conclude that NuMA/dynein is excluded from the cortical equatorial
region during anaphase in an CYK4- and MKLP1-dependent manner.
Anaphase cortical localization of NuMA is mediated by a domain
located in the C-terminal part, but not through an interaction
with 4.1 proteins
In order to decipher the mechanisms by which NuMA is targeted to
the cell cortex in a LGN/Gai1-3-independent manner during
anaphase, we generated a series of truncation constructs fused with
GFP and conducted transient transfection experiments to test which
region is sufficient for cortical targeting. This revealed that a 178
amino acid-long region (aa 1699–1876) in the C-terminal part of
NuMA (referred to as NuMAmem) can direct the fusion protein to the
plasma membrane, albeit to a lesser extent than full-length NuMA
or NuMAmem+C-ter (1646–2115) (Fig 3A–C and E). Given that this 178
amino acid-long region does not contain the NLS, such plasma
membrane localization is observed throughout the cell cycle
(Figs 5B, 6A and Supplementary Fig S3A–D). Moreover, we found
that fusing NuMAmem with NuMAC-ter, which itself cannot localize
to the plasma membrane but that harbors the CDK1 phosphoryla-
tion site T2055, leads to robust plasma membrane localization
during anaphase (Fig 3D and E). This observation suggests that
T2055 dephosphorylation during anaphase promotes robust
NuMAmem enrichment at the plasma membrane. It was recently
reported that a NuMA fragment spanning aa 1981–2060 can also
localize to the plasma membrane during anaphase (Zheng et al,
2014), compatible with the notion that several stretches of NuMA
may contribute to its presence at the membrane.
What is the biological significance of abolishing such cortical
NuMA localization? We have demonstrated that cortical dynein is
needed for proper spindle elongation during anaphase (Kotak et al,
2013), and we thus addressed whether dynein distribution is
affected in cells expressing GFP-NuMADmem and depleted of endo-
genous NuMA. We also depleted LGN in these experiments to elimi-
nate the possibility that residual LGN that may be present in
anaphase could mediate anchoring of GFP-NuMADmem when this
fusion protein is overexpressed. Importantly, we found that whereas
expression of GFP-NuMA in such a setting rescues anaphase cortical
p150Glued localization, this is not the case in cells expressing GFP-
NuMADmem, supporting the notion that NuMAmem is necessary for
dynein localization during anaphase (Fig 3F–I).
Intriguingly, a small domain within the 178 amino acid region is
known to interact with the 4.1R protein (Mattagajasingh et al, 1999;
Supplementary Fig S3E), which itself localizes to the cell cortex
through an association with integral membrane proteins (Anderson
& Lovrien, 1984). Therefore, we tested whether 4.1 proteins direct
anaphase NuMA cortical localization. We found that simultaneous
siRNA-mediated depletion of 4.1R and 4.1G (referred to as 4.1
(R + G); Supplementary Fig S3F) not only decreases cortical locali-
zation of NuMA/p150Glued during anaphase, as reported (Kiyomitsu
& Cheeseman, 2013), but also during metaphase (compare Supple-
mentary Fig S3I and J with G and H). Since 4.1 proteins are essential
for bridging the cortical actin cytoskeleton with membrane proteins
(reviewed in Baines et al, 2014), we tested whether 4.1(R + G)
depletion affects the cortical actin cytoskeleton during mitosis. As
shown in Supplementary Fig S3K–N, we found that this is indeed
the case. These results mirror the requirement of 4.1 proteins for
cortical actin integrity in interphase migrating human cells (Ruiz-
Saenz et al, 2011). We reasoned that if the consequence of 4.1
(R + G) depletion on NuMA distribution during mitosis is through
an impact on cortical actin, then cortical NuMA should be likewise
affected by perturbing the actin cytoskeleton. To test this prediction,
we treated mitotic cells with a range of concentrations of the actin
depolymerizing drug Latrunculin A (50 nM to 1 lM; Supplementary
Fig S4A–F and data not shown). We thus found that 200 nM of
Latrunculin A impairs the cortical actin cytoskeleton and leads to a
concomitant diminution of metaphase and anaphase NuMA/
p150Glued cortical localization that resembles the effects observed
upon 4.1(R + G) depletion (compare Supplementary Fig S4I and L
with S3H and J). Therefore, an intact actin cytoskeleton is required
for the presence of NuMA at the cell cortex during mitosis. Further-
more, to rigorously test whether interaction with 4.1 proteins is
important, we generated a NuMA construct lacking the 4.1 binding
region (GFP-NuMA(D4.1)). The resulting protein is unable to interact
with either 4.1R or 4.1G in co-immunoprecipitation experiments, as
anticipated (Supplementary Fig S4M). Importantly, we found that
GFP-NuMA(D4.1) nevertheless localizes to the cell cortex, in a
manner indistinguishable from wild-type GFP-NuMA, both in
metaphase and anaphase (compare Fig 1K and P with H and M).
Moreover, we found that this is also the case for GFP-NuMA(D4.1) in
LGN-depleted cells (Supplementary Fig S4N and O). Furthermore,
GFP-NuMA(D4.1, T>A), which in addition to harboring a T2055A
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mutation also lacks the 4.1 binding region, localizes like GFP-
NuMA(DLGN, T>A) (compare Fig 1L and Q with J and O). In addition,
as anticipated from the fact that GFP-NuMA(T>A) causes enrichment
of cortical dynein in metaphase (Kotak et al, 2013), we found that
GFP-NuMA(D4.1, T>A) causes excess cortical enrichment of p150
Glued
at the cell cortex (Supplementary Figs S4P–S).
Together, our findings indicate that 4.1R and 4.1G are not
directly involved in mediating NuMA cortical localization during
mitosis, a conclusion also reached by others (Seldin et al, 2013).
Furthermore, our results demonstrate that a small fragment located
in the C-terminal part of the protein is critical for anaphase cortical
NuMA localization.
Figure 2. CYK4 prevents NuMA localization in the cortical equatorial region.
A Images from time-lapse recordings of a HeLa Kyoto cell transfected with GFP-NuMA and mCherry-CYK4 (see also corresponding Supplementary Movie S1). Arrows
point to cortical NuMA localization and rectangles highlight weak CYK4 signal of CYK4 on the plasma membrane. Note that NuMA and CYK4 occupy mutually
exclusive cortical regions. Time is indicated in [hours].[minutes], with t = 0 corresponding to the onset of the recording.
B Western blot with CYK4 antibodies of lysates from cells treated with control siRNAs or CYK4 siRNAs and synchronized in prometaphase with 100 nM nocodazole.
b-actin was used as a loading control. Molecular weights are indicated in kiloDalton (kDa). Note that the specific CYK4 signal appears as a doublet.
C, D Interphase cells transfected with control siRNAs (C) or CYK4 siRNAs (D), fixed 72 h thereafter and stained for microtubules (green). DNA is visualized in white. Note
accumulation of multi-nucleated cells in CYK4-depleted cells, indicating cytokinesis failure. 90% of the cells transfected with CYK4 are multi-nucleated in contrast
to 2% in the control condition (n > 200).
E–H Metaphase and anaphase cells, as indicated, transfected with control siRNAs (E, F) or CYK4 siRNAs (G, H), fixed 48 h thereafter and stained for NuMA (red). Note
the presence of NuMA in the cortical equatorial region in CYK4-depleted cells highlighted by the rectangle. The corresponding line scan of pixel intensities (in
arbitrary units, a.u. on the y-axis) across the cortical region corresponding to the rectangle within the image is shown for one representative cell per condition. We
found that 84% of the cells exhibit NuMA in the equatorial cortical region upon transfection with CYK4 siRNAs compared to 2% in control condition (n = 50 in
each case).
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NuMA interacts with PtdInsP and PtdInsP2 in vitro
How can NuMA associate with the cell membrane during anaphase
in a manner that is independent of LGN/Gai1-3 and of 4.1 proteins?
CYK4 associates directly with plasma membrane lipids in the
cortical equatorial region (Lekomtsev et al, 2012), and since loss of
CYK4 results in NuMA expanding into that region (see Fig 2E–H),
we considered whether NuMA could also directly associate with
lipids. To investigate this possibility, we expressed and purified
recombinant NuMAmem and tested its ability to bind various lipids
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species displayed on a nitrocellulose membrane (Fig 4A and B).
Interestingly, this analysis revealed that NuMAmem, but not another
NuMA fragment that contains the LGN binding site (NuMAC-ter), can
interact with polyanionic phosphoinositides, in particular PIP and
PIP2, as well as phosphatidic acid (PA), and much more weakly
PIP3 (Fig 4C and D). Similar results were obtained in pull-down
assays using beads coated with PIP, PIP2, or PIP3 (Fig 4E). We
investigated whether the position of the phosphate moiety on PIP
and PIP2 is decisive for the interaction with NuMAmem, but found
this not to be the case (Supplementary Fig S5A and B). Such lack of
positional specificity has been observed for other lipid binding
domains, including the PIP2-interacting PH domain (reviewed in
Larijani & Poccia, 2012). Intriguingly, the two regions within
NuMAmem that are outside of the 65 residues deleted in GFP-
NuMA(D4.1) are well conserved amongst vertebrates (Supplementary
Fig S3E); these regions contain basic amino acids that may mediate
interaction with negatively charged polyanionic phosphoinositides.
CYK4 interacts with PIP and PIP2 phosphoinositides in vivo
(Lekomtsev et al, 2012), and since CYK4/MKLP1 depletion causes
NuMA to occupy the equatorial cortical region, we focused on anal-
ysing the relevance of PIP and PIP2 in NuMA cortical localization.
We explored whether these phosphoinositides are present at the
right time and at the right place to potentially interact with NuMA
during mitosis. We used time-lapse microscopy and visualized
OsH2-2xPH-GFP to monitor PtdIns(4)P (Yu et al, 2004), PLCd1PH-
GFP to monitor PtdIns(4,5)P2 (Rescher et al, 2004), as well as
PH-Akt-GFP to follow PtdIns(3,4,5)P3 (note that PH-Akt-GFP also
detects PtdIns(3,4)P2; Watton & Downward, 1999). This analysis
revealed that both PtdIns(4)P and PtdIns(4,5)P2 are present at the
plasma membrane during metaphase and anaphase (Fig 4F and G;
Supplementary Movies S2 and S3). In addition, we found an
increase in PtdIns(4,5)P2 at the cytokinesis furrow during late telo-
phase, as reported previously (Field et al, 2005; Supplementary
Movie S3). In contrast to the plasma membrane distributions of
PtdIns(4)P and PtdIns(4,5)P2, PtdIns(3,4,5)P3 appears not to be
enriched at the plasma membrane during mitosis (Fig 4H and
Supplementary Movie S4).
Taken together, the in vitro and in vivo experiments are both
compatible with the notion that NuMA associates with PIP and/or
PIP2 during mitosis.
Plasma membrane localization of NuMA depends on PIP and PIP2
We set out to address whether PIP and PIP2 modulate NuMA distri-
bution in vivo. To this end, we first depleted PIP and PIP2 from
interphase cells by subjecting them to Ionomycin and Ca2+ for
200 s (Hammond et al, 2012; Fig 5A). Importantly, we found that
this treatment triggers the rapid release of NuMAmem from the
plasma membrane to the cytosol in interphase cells (compare Fig 5C
with B). Because we found that such a short treatment with Ionomy-
cin and Ca2+ does not alter the cortical signal of OsH2-2xPH-GFP
and PLCd1PH-GFP during mitosis (data not shown), possibly reflect-
ing higher levels of PIP2, we sought to treat mitotic cells for a longer
time. We found that exposure to Ionomycin and Ca2+ for 10 min is
detrimental to the survival of anaphase cells (data not shown),
precluding us from directly testing the impact of PIP and PIP2 deple-
tion at this stage using this means. To circumvent this limitation,
and given that cells earlier in mitosis survived such a 10-min treat-
ment, we performed this experiment in metaphase cells that mimic
anaphase-like conditions through LGN depletion and RO-3306 treat-
ment. We found that membrane localization of PIP and PIP2, as
monitored with OsH2-2xPH-GFP and PLCd1PH-GFP, is substantially
diminished in such cells upon Ionomycin and Ca2+ treatment (com-
pare Supplementary Fig S5D and F with C and E). Strikingly in addi-
tion, we found that the cortical localization of NuMA/p150Glued is
severely impaired under these conditions (compare Fig 5E with D).
Since phosphoinositides are important for maintaining the integ-
rity of the actin cytoskeleton in some systems (reviewed by Yin &
Janmey, 2003), it would be conceivable that the impact of Ionomy-
cin and Ca2+ on NuMA/p150Glued localization occurs via their effect
on the cortical actin cytoskeleton, a possibility that we set out to
evaluate. We found that exposure to Ionomycin and Ca2+ leads to a
dramatic loss of internal stress fibers in interphase cells (compare
Supplementary Fig S5H with G). By contrast, we found that short-
term treatment with Ionomycin and Ca2+ has not apparent impact
on the actin cytoskeleton in mitosis (compare Supplementary Fig
S5J with I). We also performed a converse experiment by analysing
PIP2 localization using the PLCdPH-GFP probe upon the addition of
1 lM Latrunculin A, and again found no apparent difference from
the control (compare Supplementary Fig S5L with K). Overall, we
conclude that phosphoinositides regulate NuMA/p150Glued localiza-
tion independently of their influence on the actin cytoskeleton.
Next, we set out to selectively hydrolyse phosphoinositides at the
plasma membrane instead of depleting them from the entire cell as
upon Ionomycin and Ca2+ treatment. To this end, we utilized a
construct in which Rapamycin induction targets the hybrid lipid
phosphatase pseudojanin (PJ) to the plasma membrane, thus deplet-
ing PIP and PIP2 selectively in that location (Fig 5A; Hammond
et al, 2012). Importantly, we found that Rapamycin-mediated
plasma membrane targeting of PJ causes the rapid release of
Figure 3. A small domain in the C-terminus of NuMA interacts with the plasma membrane.
A Schematic representation of NuMA constructs, as in Fig 1G. ++ (strong), + (weak), or  (absent) indicates whether the respective GFP-tagged constructs localize to
the cortex during anaphase (depicted as ana/cortex).
B–E Anaphase cells transfected with GFP-NuMA (aa 1–2115, B), GFP-NuMAmem (aa 1699–1876, C), GFP-NuMAC-ter (aa 1877–2115, D), or GFP-NuMAmem+C-ter (aa 1646–
2115, E) for 36 h and stained for GFP (green). More than 20 cells were analysed by visual inspection in each case. Moreover, quantification of cortical enrichment is
shown on the right for 10 cells in each condition (error bars, s.d.). Note localization of GFP-NuMAC-ter (aa 1877–2115) to chromosomes, which was observed in all
cells for reasons that remain to be determined. Also note the equatorial localization of GFP-NuMAmem+C-ter (marked by arrowheads).
F–I Untransfected cells treated with control siRNAs (F) or NuMA siRNAs plus LGN siRNAs (G), as well as cells transfected with GFP-NuMA (H) or with GFP-NuMADmem (I) and
treated with NuMA plus LGN siRNAs, all stained for GFP (green) and p150Glued (red). More than 23 cells were analysed by visual inspection in each case, and
representative image is shown. Note that 60% of the GFP-NuMADmem-expressing cells exhibit no apparent GFP signal at the membrane, as shown, 30% weak GFP
signal and 10% strong GFP signal, analogous to GFP-NuMA. Note also that GFP-NuMADmem-expressing cells show excess blebbing in mitosis. Quantification of
anaphase cortical p150Glued enrichment is shown on the right for 10 cells in each condition (P < 0.0005 between GFP-NuMA transfected and untransfected cells treated
with NuMA plus LGN siRNAs, P < 0.005 between GFP-NuMA-transfected and GFP-NuMADmem-transfected cells also treated with NuMA plus LGN siRNAs; error bars, s.d.).
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NuMAmem from the plasma membrane (compare Fig 6B with A).
We also analysed the distribution of endogenous cortical NuMA
by this means and found it to be drastically reduced following
Rapamycin-mediated plasma membrane targeting of PJ (compare
Fig 6D with C). As anticipated from the experiments using Iono-
mycin and Ca2+, we found also that Rapamycin-mediated plasma
Figure 4. NuMA interacts with polyanionic phosphoinositides in vitro and phosphoinositides distribution in mitosis.
A Recombinant purified hexa-histidine-tagged NuMAmem (aa 1699–1876) or NuMAC-ter (aa 1877–2115) run on SDS–PAGE and stained with Coomassie blue. Molecular
mass is indicated in kiloDaltons (kDa). Note that bacterially expressed NuMAC-ter is unstable, thus explaining the presence of two major species. Asterisks mark
expected molecular weight for each species.
B–D Lipid arrays (B) incubated with NuMAmem (C) or NuMAC-ter (D) and subsequently probed with anti-His antibodies. Key: triglyceride (TG), diacylglycerole (DAG),
phosphatidic acid (PA), phosphatidylserine (PS), phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidylglycerole (PG), cardiolipin (CL),
phosphatidylinositol (PI), phosphatidylinositol-4-phosphate PI(4)P, phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2], phosphatidylinositol 3,4,5-triphosphate
[PI(3,4,5)P3], cholesterol (Chol.), sphingomyelin (SM), sulfatide (Sulf.).
E Pull-down assay using recombinant NuMAmem, incubated with control beads or beads coated with indicated phosphoinositides. Recovered proteins were run on
SDS–PAGE and subsequently probed with anti-His antibodies. Molecular mass is indicated in kiloDaltons (kDa).
F–H Images from time-lapse microscopy of HeLa cells stably expressing mCherry-H2B and transfected with OsH2-2xPH-GFP (F), PLCdPH-GFP (G), or PH-Akt-GFP (H) (see
also corresponding Supplementary Movies S2, S3 and S4). The mCherry signal is shown in pink, the GFP signal in white. Time indicated in [hours].[minutes].
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membrane targeting of PJ does not alter the cortical actin cytoskele-
ton during anaphase or other stages of mitosis (Supplementary Fig
S5M and N, data not shown). These experiments lead us to
conclude that plasma membrane PIP and/or PIP2 phosphoinositides
are essential for anaphase cortical NuMA localization.
As a further test of the contribution of PIP2 for cortical NuMA
localization, we set out to deliver synthetic PtdIns(4,5)P2 to the cyto-
sol with a cationic histone carrier, a method previously used to alter
lipid distribution (Ozaki et al, 2000; Weiner et al, 2002). We
reasoned that if PIP2 can interact with NuMA at the cell membrane,
then artificially elevating the levels of PIP2 in the cytosol should
compete with and thus decrease the levels of cortical NuMA. As
anticipated from this prediction, upon delivery of PtdIns(4,5)P2—
histones complexes, we observed a diminution of the cortical GFP
signal in cells expressing GFP-NuMA(T>A) (compare Fig 6F with E),
although cortical PLCd1PH-GFP does not seem altered (data not
shown). Perhaps this indicates tighter binding of PtdIns(4,5)P2—
histones complexes to NuMA then to PLCd1PH-GFP or, conversely,
stronger affinity of PLCd1PH-GFP than NuMA to the plasma
membrane. By contrast, we found that delivery of carrier histone
alone or complexed with PtdIns(3,4,5)P3 does not alter levels of corti-
cal GFP-NuMA(T>A) (Supplementary Fig S5O–R). These results estab-
lish that NuMA can interact with PIP2 in vivo. Whether PIP may do
so as well remains to be determined.
We then set out to address whether, conversely, increasing the
levels of PIP2 at the cell membrane leads to an increase of cortical
Figure 5. Membrane localization of NuMA depends on PtdIns(4)P and PtdIns(4,5)P2 in vivo.
A Schematic representation of the involvement of inhibitors and activators of PIP and PIP2 biosynthesis. Treatments that lead to increases in the levels of PIP and/or
PIP2 are shown in green, those that result in corresponding decreases in red. Ionomycin and CaCl2 (Iono + Ca
2+) treatment activates phospholipase C and thus
decreases the levels of PIP and PIP2. INPP5E and Sac are part of the hybrid lipid phosphatase pseudojanin (PJ), which deplete PIP2 and PIP when targeted to the
membrane using Rapamycin-based chemistry (see text for details). PI(4)P5K converts PI(4)P to PI(4,5)P2, thus resulting in increased PtdIns(4,5)P2 levels when
targeted to the membrane. LY294002 is a PI3K inhibitor that enriches PIP2 upon PI3K inhibition.
B, C HEK293T interphase cells transfected with GFP-NuMAmem recorded before (control) and 200 s after treatment with 10 lM Ionomycin (Iono) and 1 mM CaCl2, with
higher magnifications of the cortical regions highlighted by the yellow rectangle. Quantification of cortical enrichment is shown on the right in this and other
panels of this figure and Fig 6A; see Materials and Methods (P = 0.003; n = 10 cells each; error bars, s.d.).
D, E Metaphase HeLa cells transfected with siRNAs against LGN and treated with RO-3306 for 5 min (D) or treated with Ionomycin and CaCl2 (10 min) plus RO-3306 for
5 min (E) and stained for NuMA (red) as well as p150Glued (green) (P < 0.001; n = 10; error bars s.d.). We note also that 98% of LGN (RNAi) and RO-3306-treated
cells exhibited strong cortical NuMA/p150Glued staining, as shown in (D), but this was the case for only 14% of LGN (RNAi); RO-3306; Ionomycin and CaCl2-treated
cells (n > 50 cells for all cases).
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NuMA during anaphase. We utilized a distinct Rapamycin-based
targeting method to enrich levels of PIP2 at the plasma membrane
by delivering PI(4)P 5-kinase [PI(4)P5K], which converts PI(4)P to
PI(4,5)P2, thus resulting in increased PtdIns(4,5)P2 levels (Ueno
et al, 2011; Fig 5A). Remarkably, we found that this markedly
increases the levels of cortical NuMA during anaphase (compare
Fig 6H with G).
Overall, these results converge to support the notion that the
plasma membrane localization of NuMA during anaphase is dictated
by PIP2 and perhaps also by PIP.
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Prematurely enriching PIP2 during metaphase perturbs
spindle positioning
Experiments with drugs that impair the activity of phosphatidylinos-
itide 3-kinases (PI3K) had implicated PtdIns(3,4,5)P3 in dynein-
dependent spindle positioning during metaphase (Toyoshima et al,
2007). However, the nature of the protein whose distribution or
function is affected by such drug treatment had not been deter-
mined. Because PI3K are involved in converting PIP2 to PIP3
(Fig 5A) and since we found that NuMA can directly interact with
PIP and/or PIP2, we reasoned that the reported metaphase spindle
positioning phenotype upon PI3K inactivation may be due to excess
cortical NuMA. We found that metaphase cells treated with the PI3K
inhibitor LY294002 indeed exhibit increased PIP2 levels at the cell
membrane as monitored with PLCd1PH-GFP (Fig 7A and B), in line
with findings in interphase neuronal cells (Saengsawang et al,
2013). Interestingly, we found in addition that cortical NuMA levels
in metaphase are increased under such conditions (compare Fig 7D
with C and Supplementary Movies S5 and S6). We then tested
whether cells treated with LY294002 exhibit NuMA-dependent meta-
phase spindle positioning phenotypes. We monitored spindle posi-
tioning by analysing fixed cells on coverslips coated with an
L-shaped fibronectin micropattern or on coverslips coated with
uniform fibronectin (Supplementary Fig S6A–G; The´ry et al, 2005;
Toyoshima & Nishida, 2007). We found that spindle positioning is
randomized in cells on both types of coverslips upon treatment with
LY294002 (compare Supplementary Fig S6D and G with C and F;
Toyoshima et al, 2007). Similarly, live-imaging experiments of cells
treated with LY294002 uncovered dramatic chromosome oscilla-
tions, indicative of excess dynein-mediated pulling forces acting on
the spindle poles, which are suppressed by NuMA depletion
(Fig 7E–G; Supplementary Movies S7, S8 and S9). Importantly in
addition, we found that LY294002-induced chromosome oscillations
are suppressed in cells also treated with Ionomycin and Ca2+ (com-
pare Supplementary Fig S6I with H; Supplementary Movies S10 and
S11), together suggesting that increases in PIP2/NuMA are responsi-
ble for excess movements upon LY294002 treatment.
Discussion
The temporal and spatial regulation of dynein distribution is of criti-
cal importance for the proper execution of mitosis (reviewed in
Kardon & Vale, 2009; Raaijmakers et al, 2013). Here, we propose a
novel mechanism whereby NuMA directs dynein to the cell cortex
during anaphase through direct association with phosphoinositides
(Fig 7H).
Switching from the ternary complex to phosphoinositides
An evolutionary conserved ternary complex is important during
metaphase for ensuring that low levels of dynein are present in the
polar regions of the cell cortex, from where the motor protein directs
spindle positioning by exerting pulling forces on astral microtubules
(Woodard et al, 2010; Kiyomitsu & Cheeseman, 2012; Kotak et al,
2012). The excess, as well as the lack, of cortical dynein during
metaphase impairs spindle positioning, underscoring the importance
of achieving proper levels of cortical dynein (Kotak et al, 2012).
During metaphase, this is achieved by a tug-of-war between CDK1
kinase and PPP2CA phosphatase acting on T2055 of NuMA,
whereby CDK1 negatively and PPP2CA positively regulate cortical
NuMA/dynein levels (Kotak et al, 2013). At anaphase onset, CDK1
inactivation results in augmented levels of non-phosphorylated
cortical NuMA and thus of dynein, which promotes spindle
elongation during anaphase B (Collins et al, 2012; Kiyomitsu &
Cheeseman, 2013; Kotak et al, 2013). As reported also by others
(Kiyomitsu & Cheeseman, 2013; Seldin et al, 2013; Zheng et al,
2014), we found here that the ternary complex components LGN/
Gai1-3 are dispensable for NuMA-dependent enrichment of cortical
dynein in the polar regions during anaphase.
We discovered instead that a region of NuMA encompassing aa
1699–1876 possesses the ability to bind phosphoinositides in vitro,
including PIP and PIP2. A related observation has been reported
recently for another NuMA fragment, encompassing aa 1981–2060,
which can bind a partially overlapping set of phosphoinositides in
vitro, including PIP and PIP2 (Zheng et al, 2014). Furthermore, that
study reported that the plasma membrane localization of such a
fragment fused to GFP depends on phosphoinositides in interphase
(Zheng et al, 2014). However, whether this is also the case during
mitosis, whether that fragment is not only sufficient but also neces-
sary for such localization, and whether endogenous anaphase
NuMA localization is dependent on phosphoinositides were not
assessed in that study. Together with our findings, those observa-
tions raise the possibility that NuMA binds the plasma membrane
through several basic residues present in the 1699–1876 and 1981–
2060 fragments. Regardless, and importantly, by experimentally
changing the cortical levels of phosphoinositides in vivo, we
unequivocally demonstrate here that PIP and/or PIP2 regulate the
Figure 6. Membrane localization of NuMA depends on PIP2 and/or PIP phosphoinositides in vivo.
A, B HEK293T cells co-transfected with GFP-NuMAmem, Lyn11–FRB, and monomeric red fluorescent protein (mRFP)-FKBP-tagged lipid phosphatases [pseudojanin (PJ);
Hammond et al, 2012]. Images were taken before (control) and 200 s after treatment with 10 lM Rapamycin (Rap) (P < 0.001; n = 10; error bars: s.d.).
C, D Anaphase HeLa cells either untransfected (C) or co-transfected with Lyn11-CFP-FRB and mRFP-FKBP-tagged lipid phosphatases [pseudojanin (PJ); Hammond et al,
2012] for 36 h (D) and treated with Rapamycin for 10 min thereafter. Cells were fixed and stained for NuMA (red) and CFP to detect PJ (green) (P < 0.0005; n = 5
cells each; error bars, s.d.). Note that we could only obtain very few mitotic cells expressing PJ and also that we noticed a major incidence of apoptosis in
PJ-expressing cells.
E, F Images from time-lapse microscopy of HeLa cells stably expressing mCherry-H2B and transfected with GFP-NuMAT>A, and imaged in three confocal sections either
at the onset of the experiment (E) or 20 min after addition of PI(4,5)P2—histone complexes (F). The mCherry signal is shown in pink, the GFP signal in white
(P = 0.0019; n = 5 cells in each condition; error bars, s.d.).
G, H Anaphase HeLa cells either untransfected (G) or co-transfected with YFP-FKBP-PI(4)P5K; LYN11-FRB for 24 h (H) and treated with 10 lM Rapamycin (Rap) for
10 min. Cells were fixed and stained for NuMA (red) and GFP (green) (P = 0.0006; n = 9 in each condition; error bars: s.d.). Note that only very few mitotic cells
expressing GFP-FKBP-PI(4)P5K during mitosis could be obtained, suggesting that altering phosphoinositide levels in the cytoplasm, prior to Rap addition, impairs
cell viability or cell cycle progression.
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cortical localization of both GFP-tagged and endogenous NuMA.
Despite the fact that NuMA directly associates with PIP and PIP2 in
vitro, we cannot formally exclude the possibility that another, as of
yet unknown, protein would mediate interaction of NuMA with
phosphoinositides in vivo.
Restricting NuMA/dynein to the polar regions of the cell
In addition to revealing a switch in the mechanism directing NuMA/
dynein to the polar regions of the cell between metaphase and
anaphase, our study uncovers a novel mechanism preventing their
accumulation in the cortical equatorial region when comparing
these two stages of the cell cycle. During metaphase, Ran-GTP
emanating from the centrally located chromosomes prevents
association of NuMA/dynein with the equatorial cortical regions
(Kiyomitsu & Cheeseman, 2012; Bird et al, 2013). Such restriction of
NuMA/dynein to the polar regions is important for proper spindle
positioning. During anaphase, we show here that CYK4 and MKLP1,
but not Ran-GTP, exert an analogous role. Preliminary results failed
to reveal an impact on spindle elongation in cells depleted of
centralspindlin components (data not shown), such that the poten-
tial importance of preventing NuMA/dynein from occupying the
equatorial region remains to be determined.
Because CYK4 interacts with polyanionic phosphoinositides
through its C1 domain (Lekomtsev et al, 2012), and because
NuMAmem can also directly interact with polyanionic phosphoinosi-
tides, one tempting possibility is that both proteins compete for the
same lipid moieties on the plasma membrane. However, fragments
of NuMA fused to GFP that contain the anaphase membrane target-
ing sequences are not excluded from the equatorial region, suggest-
ing that the postulated competition mechanism is more complex,
with the N-terminal moiety of NuMA playing a role, perhaps owing
to its ability to interact with dynein (Kotak et al, 2012). Further-
more, overexpression of full-length GFP-NuMA does not cause
apparent cytokinesis abnormalities (data not shown). This suggests
that excess NuMA is not sufficient to displace CYK4 from the equa-
torial region, perhaps because CYK4 has a higher local concentra-
tion and/or higher affinity toward phospholipids.
Anaphase-specific association with phosphoinositides
Why does the phosphoinositide-dependent mechanism that anchors
NuMA to the polar regions of the cell normally not act during meta-
phase, since PIP and PIP2 are already available at the plasma
membrane at that stage? One plausible explanation is that the little
non-phosphorylated NuMA normally present during metaphase has
a higher affinity toward LGN/Gai1-3 than toward PIP and/or PIP2. In
this scenario, only when a large excess of non-phosphorylated
NuMA or an increase in PIP and/or PIP2 levels occurs could binding
to phosphoinositides be revealed. This view is in line with the
observation that either mimicking anaphase-like condition by acute
inhibition of CDK1 or increasing the levels of cell membrane PIP2
through PI3K inhibition leads to premature cortical NuMA enrich-
ment during metaphase, resulting in NuMA-dependent spindle posi-
tioning phenotypes. In C. elegans embryos, the polarity protein
PAR-2, which can associate with phosphoinositides, is prevented
from doing so if phosphorylated by PKC-3 (atypical protein kinase-3)
(Motegi et al, 2011). By analogy, perhaps NuMA does not bind to
phosphoinositides during metaphase because the bulk of NuMA is
phosphorylated during that time. Irrespective of the actual mecha-
nism, our work suggests that NuMA and thus dynein switch from a
LGN/Gai1-3-dependent to a phosphoinositide-dependent mode of
targeting to the plasma membrane between metaphase and
anaphase (Fig 6H).
Intriguingly, it was proposed in C. elegans embryos that the corti-
cal distribution of the ternary complex components GPR-1/2 and
LIN-5, which are related to LGN and NuMA, respectively, is regu-
lated by PI(4,5)P2 (Panbianco et al, 2008), indicating that the mecha-
nism uncovered here may be evolutionary conserved.
Materials and Methods
Cell culture, siRNA treatment, and plasmid transfection
HeLa cells expressing GFP-Centrin 1 (Piel et al, 2000), HeLa Kyoto
cells expressing EGFP-a-tubulin and mCherry-H2B (Schmitz et al,
2010), HeLa cells expressing mCherry-H2B as well as HEK293T
cells were maintained as described previously (Kotak et al, 2013).
Spindle positioning assays using fixed synchronized metaphase cells
on coverslips uniformly coated with fibronectin (BD-Bioscience,
354088) were conducted as described earlier (Kotak et al, 2012,
2013). In addition to monitoring spindle positioning on uniform
fibronectin as previously, here we also utilized fibronectin L-shape
micropatterns (CYTOO SA), plating approximately 60,000 cells per
chip in a 35-mm culture dish. After 1 h, cells that had not attached
to these micropatterns were removed by gently washing with media.
Cells were then fixed with PTEMF buffer (20 mM PIPES, pH 6.8,
Figure 7. Premature enrichment of PtdInsP2 (PIP2) causes NuMA-dependent spindle positioning defects.
A, B Images from time-lapse microscopy of mitotic HeLa cells stably expressing mCherry-H2B and transfected with the PIP2-specific marker (PLCdPH-GFP) either treated
with DMSO (Control) (A) or treated with 100 lM of the PI3K inhibitor LY294002 (B). Quantification of GFP cortical signal (right) was determined as mentioned in
Materials and Methods. The mCherry signal is shown in pink and the GFP signal in white (P = 0.005; n = 10 cells in each condition; error bars, s.d.).
C, D Z-projection of images 2 lm apart of metaphase cell treated with DMSO (Control) or LY294002 and stained for NuMA (red). See corresponding Supplementary
Movies S5 and S6 of the entire z-stack. 50 cells were analysed for each condition and representative results shown here.
E–G Images from time-lapse recordings of metaphase HeLa Kyoto cells stably expressing GFP-a-tubulin as well as mCherry-H2B (E) and treated with DMSO (Control)
(E), LY294002 (F), and depleted of NuMA plus treated with LY294002 (G) (see also corresponding Supplementary Movies S7, S8, and S9). The white line indicates the
position of chromosomes. Ten cells were imaged for each condition. The bar graphs on the right represent the frequency at which chromosome position changes
> 10° between two frames, along with the standard deviation (s.d.). Time is indicated in [hours].[minutes], (P < 0.0005 between control (DMSO) and LY294002, as
well as between LY294002 and LY294002 plus NuMA (RNAi); error bars, s.d.).
H Model for cortical localization of NuMA/dynein during metaphase, and anaphase. During metaphase, when CDK1 is active, the LGN/Gai(1–3)-dependent pathway is
responsible for cortical NuMA/dynein localization. By contrast, during anaphase, upon CDK1 inactivation, a PIP- and/or PIP2-based mechanism ensures cortical
NuMA/dynein localization. Also note that CYK4/MKLP1 exclude NuMA/dynein from the equatorial cortical region in anaphase.
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10 mM EGTA, 1 mM MgCl2, 0.2% Triton X-100, 4% formaldehyde)
for 10 min and stained with antibodies against c-tubulin. siRNA
experiments were performed as described (Kotak et al, 2012, 2013),
In brief, 6 ll of 20 lM siRNAs in 100 ll OptiMEM medium (Invitro-
gen) and 4 ll of Lipofectamine RNAiMAX (Invitrogen) in 100 ll
OptiMEM were incubated in parallel for 5 min, mixed for 20 min
and then added to 2.5 ml medium per well containing approxi-
mately 100,000 cells. For plasmid transfections, 4 lg of plasmid
DNA in 100 ll OptiMEM and 4 ll of Lipofectamine 2000 (Invitro-
gen) or 6 ll Turbofect (Thermo Scientific) in 100 ll OptiMEM were
incubated in parallel for 5 min, mixed for 20 min, and added to
each well.
Plasmids and RNAi
All NuMA clones were constructed using full-length NuMA as a
template with appropriate PCR primer pairs (the sequences of all
primers are available upon request). The amplified products were
subcloned into pcDNA3-GFP (Merdes et al, 2000). The Rapamycin-
regulated membrane-targeted system of lipid phosphatases is
described in detail in Hammond et al, 2012. In brief, HEK293T cells
were transfected with GFP-NuMAmem, Lyn11-FRB and a plasmid
containing pseudojanin (PJ) (pmRFP- C1-FKBP-PJ); HeLa cells were
transfected with plasmids containing PJ and LYN11-CFP-FRB. PJ
contain polyphosphate-5-phosphatase E (INPP5E), which converts
PtdIns(4,5)P2 to PtdIns(4)P, and Sac1 phosphatase (Sac), which
dephosphorylates PtdIns(4)P. Similarly, the Rapamycin-based
membrane targeted system of the lipid kinase PI(4)P5K is described
in detail in Ueno et al (2011). In short, HeLa Kyoto cells were trans-
fected with plasmids expressing GFP-FKBP-PI(4)P5K and LYN11-FRB.
PI(4)P5K converts PI(4)P to PI(4,5)P2.
Double-stranded siRNA oligonucleotides were synthesized with
the sequences:
UAGGAAAUCAUGAUCAAGCAA (LGN -siRNA, Qiagen)
GACUGCAGAACUUGCUGGAGUUAUA (Gai1 -Stealth siRNA, Invi-
trogen)
GCCGUCACCGAUGUCAUCAUCAAGA (Gai2 -Stealth siRNA, Invitrogen)
CCAAAGAAGUGAAGCUGCUGCUACU (Gai3 -Stealth siRNA, Invitrogen)
GACGGUUAUUAAACCUGAAUCCUGU (CYK4 -Stealth siRNA, Invi-
trogen) and CAGGAUGUACAGAAG UUGAAGUGAA (MKLP1
-Stealth siRNA, Invitrogen).
In the cases where wild-type or mutant NuMA fusion constructs
were expressed in NuMA-depleted cells, endogenous NuMA was
depleted using the siRNAs sequence CCUCUGGAUCUAGAAGGGAC-
CAUAA (NuMA -Stealth siRNA, Invitrogen) targeting the 30UTR of the
endogenous messenger, which is absent from the fusion constructs.
Other sequences targeting NuMA and 4.1(R + G) are mentioned in
Kotak et al (2013) as well as in Kiyomitsu and Cheeseman (2013).
Additional siRNAs were tested for LGN and CYK4, with a similar
impact on anaphase NuMA/p150Glued localization. Cells were incu-
bated with Pertussis toxin (List Biologicals, 181214A1) at 400 ng/ml
for 4 h before analysis. For RanGFP/importin-b inhibition, cells
were treated with 50 lM Importazole (Sigma-Aldrich, SML0341) for
10 min. CDK1 inhibition was performed by treating metaphase
synchronized cells for 5 min with RO-3306 (Vassilev et al, 2006)
(9 lM; Santa Cruz, sc-358700) For PIP and PIP2 inhibition, inter-
phase and mitotic cells were treated with 10 lM Ionomycin (Calbio-
chem, 407950) and 1 mM Ca2+ for 200 s (interphase cells) and for
10 min (mitotic cells). Rapamycin (Sigma-Aldrich, R8781) was used
at the concentration of 10 lM for 5 min for interphase cells and for
10 min for mitotic cells. For PI3K inhibition, cells were treated with
100 lM LY294002 (Cell Signaling, 9901). Actin, depolymerization
was provoked with a range of concentrations (50 nM–1 lM) of
Latranculin A (Sigma-Aldrich, L5613) for 10 min.
Indirect immunofluorescence and time-lapse imaging
of HeLa cells
For immunofluorescence, cells were fixed in cold methanol and
stained with the respective antibodies as described previously
(Kotak et al, 2012, 2013). Primary antibodies were 1:200 rabbit anti-
NuMA (Santa Cruz, sc-48773), 1:200 rabbit anti-LGN (Sigma-
Aldrich, HPA007327), 1:200 mouse anti-p150Glued (Transduction
Laboratories, 612709), 1:2,000 mouse anti-c-tubulin (GTU88; Sigma-
Aldrich), 1:300 mouse anti-GFP (MAB3580; Millipore), 1:500 rabbit
anti-GFP (gift from V. Simanis), and 1:1,000 mouse anti-actin
(Abnova, MAB8172).
Secondary antibodies were Alexa488 anti-mouse, Alexa488 anti-
rabbit, Alexa568 anti-mouse, and Alexa568 anti-rabbit, all used at
1:500 (Invitrogen). Confocal images were acquired on a Zeiss LSM
710 confocal microscope equipped with a Axiocam MRm (B/W)
CCD camera using a 63× NA 1.0 oil objective and processed in
ImageJ and Adobe Photoshop, maintaining relative image intensities
within a series.
Time-lapse microscopy was conducted on a Zeiss LSM 700 confo-
cal microscope using a Axiocam MRm (B/W) CCD camera and a
40× NA 1.3 oil objective, in a Hi Q4 dish (Ibidi) at 5% CO2, 37°C,
90% humidity. Images were acquired every 3 min, capturing 4–5
sections, 7 lm apart at each time point. Time-lapse figures and
movies were obtained using single confocal section of the Z-stack.
Spindle positioning assay
The angle of the metaphase spindle with respect to the fibronectin
substratum was determined as described (Toyoshima & Nishida,
2007; Kotak et al, 2012, 2013). Briefly, cells were stained with
c-tubulin antibodies and counterstained with 1 lg/ml Hoechst
33342 (Sigma-Aldrich). Stacks of confocal images 0.4 lm apart were
acquired and the distances between the two spindle poles in Z and
in XY determined using Imaris (Bitplane Inc.); the spindle angle to
the substratum was then calculated using inverse trigonometry.
Spindle positioning assay during live imaging
The bar graphs in live-spindle positioning assays are readouts of the
extent of spindle oscillations, representing the frequency at which
chromosome position changes > 10° between two frames (including
when they move out of the imaging plane), along with the standard
error of the mean (SEM). Two-tailed Student’s t-tests were
performed to determine the extent of spindle oscillations in various
conditions.
Quantification of cortical intensity
Quantification of GFP cortical signal was determined by calculating
the ratio of the mean intensity of the cortical signal divided by the
The EMBO Journal Vol 33 | No 16 | 2014 ª 2014 The Authors
The EMBO Journal NuMA interacts with phosphoinositides Sachin Kotak et al
1828
mean intensity value in the cytoplasm (similar area) and correcting
for background signal. Significance was determined using two-tailed
Student’s t-test for each condition.
Immunoprecipitation and immunoblotting
For co-immunoprecipitations, 3 mg of cell lysate were incubated
with 30 ll GFP-Trap agarose beads (Chromotek, ACT-CM-GFA0050)
in lysis buffer (10 mM Tris, pH 7.5; 150 mM NaCl; 0.5% NP-40;
0.5 mM EDTA; complete EDTA-free protease inhibitor tablet
(11873580001, Roche)) for 4 h at 4°C. After extensive washing in
wash buffer (10 mM Tris, pH 7.5; 150 mM NaCl; 0.5 mM EDTA;
complete EDTA-free protease inhibitor tablet (Roche), the beads
were denatured at 95°C in 2× SDS–PAGE buffer and analysed by
SDS–PAGE and immunoblotting. For immunoblotting, 1:2,000
mouse anti-GFP (MAB3580, Millipore), 1:1,000 rabbit anti-CYK4
(A302-797A, Bethyl Laboratories), 1:500 rabbit anti-4.1G (A301-
424A, Bethyl Laboratories),1:1,000 rabbit anti-4.1R (13014-1-AP,
Protein Tech Group), and 1:10,000 mouse anti-actin (ABNOVA,
MAB8172) primary antibodies were used; 1:5,000 anti-rabbit HRP
(W4011, Promega) or 1:5,000 anti-mouse HRP (W4021, Promega)
was used as secondary antibodies for Western blotting.
Lipid binding assay
His-NuMAmem (residues 1699–1876 with an hexa-histidine N-termi-
nal fusion) and His-NuMAC-ter (residues 1877–2115 with an hexa-
histidine N-terminal fusion) were expressed in the E. coli strain
BL21. Membrane lipid arrays (P-6002 and P-6100, Echelon
Biosciences) were incubated with 200 ng/ml of His-NuMAmem
or His-NuMAC-ter in PBS containing 0.1% Tween-20 (PBST) and 3%
BSA for 1 h at 25°C according to the manufacturer’s protocol.
After washing with PBST, proteins were detected using anti-His
antibodies.
Cellular lipid delivery assay
The phosphoinositides—histone complexes were delivered intracel-
lularly as described (Ozaki et al, 2000). Briefly, the histone—phos-
phoinositides complex was prepared using 300 lM of long-chain
(Di-C16) phosphoinositides PI(4,5)P2 (P4516; Echelon Bioscience),
PI(3,4,5)P3 (P-3916; Echelon Bioscience) with 100 lM of carrier
histone (P-9C2; Echelon Bioscience). Twenty microlitre of each
component were mixed, vortexed vigorously, and incubated at room
temperature for 5–10 min before adding to the cells. Lipid delivery
assays were performed in cells expressing GFP-NuMA(T>A), which
mimics anaphase-like NuMA cortical localization (Kotak et al,
2013) and provides a time-window of up to 30 min to perform such
experiments, in contrast to the much more rapid anaphase.
Supplementary information for this article is available online:
http://emboj.embopress.org
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